Overview
Lobbying Costs
50,000€ - 99,999€
Financial year: Jan 2023 - Dec 2023
Lobbyists (Full time equivalent)
1.5 Fte (3)
Lobbyists with EP accreditation
1
High-level Commission meetings
3
Lobbying Costs over the years
-
Info
Hellenic Association of Pharmaceutical Companies (SFEE)
EU Transparency Register
684432824847-17 First registered on 01 Dec 2016
Goals / Remit
The Hellenic Association of Pharmaceutical Companies (SFEE) represents one of the most innovative, productive, and extrovert sectors of the national economy. It encompasses more than 95% of the pharmaceutical industry operating in Greece. Its 61 member companies, national and multinational, are constantly investing in developing effective medicines and treatments to safeguard the right of all citizens to health and better quality of life.
SFEE was established in 1982 and has championed the common interests of patients, pharmaceutical companies, and their workforce. Since 1983, SFEE has been a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA), the voice of the pharmaceutical industry at the European Union level. SFEE is also a member of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and the Europen Confederation of Pharmaceutical Entrepreneurs (EUCOPE).Main EU files targeted
- European Pharmaceutical Strategy
- Green Deal
- EU Industrial Strategy
-EU Health Data Space
- Review of the OMP and Paediatrics Regulations
- European HTA
- European Presidencies
- Patients' Access to healthcare
- Cross-country collaborations
- European Semester
-Any other direct or indirect initiative affecting healthcare and pharmaceuticalsAddress
Head Office
3 Agriniou street
Halandri 15232
GREECEEU Office
3 Agriniou street
Halandri 15232
GREECEWebsite
-
People
Total lobbyists declared
3
Employment time Lobbyists 50% 3 Lobbyists (Full time equivalent)
1.5
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
1 accreditations were / are live (in bold) for the selected state of 21 Dec 2024
Name Start date End Date POLYXENI PAPADONIKOLAKI 23 Sep 2024 23 Sep 2025 Complementary Information
These activities are under the Public Affairs Director (‘employee’), who is the main responsible, with the participation of the General Manager and the President of the Association.
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Trade and business associations
-
Networking
Affiliation
SFEE is a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA)
http://efpia.eu/
SFEE is a member of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)
https://www.ifpma.org/
SFEE is a member of the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)
https://www.eucope.org/
SFEE is a member of the Hellenic Federation of Enterprises (SEV)
http://www.sev.org.grMember organisations
https://www.sfee.gr/en/sfee/members/
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jan 2023 - Dec 2023
Lobbying costs for closed financial year
50,000€ - 99,999€
Major contributions in closed year
None declared
Intermediaries for closed year
None declaredIntermediaries for current year
None declaredClosed year Costs
50,000€ - 99,999€
Other financial info
For our EU activities, we have not used or hired any intermediary to advance our interests over the last three years or currently ( at the time of the update).
-
EU Structures
Groups (European Commission)
None declared
Groups (European Parliament)
N/A
Communication activities
-Publication of studies and reports in collaboration with external parties
-Public events with stakeholders (policy debates, roundtable discussions, policy conferences)
-Advocacy activitiesOther activities
None declared
Meetings
Meetings
3 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.
-
Date 08 Apr 2022 Location Delphi Subject Pharma strategy in EU and Greece Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Margaritis Schinas (Vice-President)
-
Date 01 Oct 2020 Location Virtual event Subject EU Health Policies Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Margaritis Schinas (Vice-President)
- Maria Luisa Llano Cardenal (Cabinet member)
-
Date 29 Nov 2016 Location Berlaymont Subject exchange of vies on Pharmaceutical products distribution in refugee camps in Greece Cabinet Cabinet of Commissioner Christos Stylianides Portfolio Humanitarian Aid & Crisis Management Attending - Christos Stylianides (Commissioner)